CRP, an acute-phase reactant that is elevated in systemic inflammation, is also associated with endothelial dysfunction and increased vascular stiffness, worsening cardiovascular complications in COPD-T2DM patients [19]. Here, CRP is linked to type 2 diabetes mellitus.